General MedicationsORALGeneric

TOLMETIN SODIUM

Standard Dose

EQ 400MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview TOLMETIN SODIUM is listed in Drugs@FDA under application 073519 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient TOLMETIN SODIUM Form and strength CAPSULE;ORAL - EQ 400MG BASE Sponsor ANI PHARMS Submission history Latest submission status date: 2021-04-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview TOLMETIN SODIUM is listed in Drugs@FDA under application 073519 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TOLMETIN SODIUM Form and strength CAPSULE;ORAL - EQ 400MG BASE Sponsor ANI PHARMS Submission history Latest submission status date: 2021-04-28 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.